Hong Kong · Delayed Price · Currency is HKD Immunotech Biopharm Statistics
Total Valuation
HKG:6978 has a market cap or net worth of HKD 240.83 million. The enterprise value is 282.04 million.
| Market Cap | 240.83M |
| Enterprise Value | 282.04M |
Important Dates
The last earnings date was Friday, August 21, 2026.
| Earnings Date | Aug 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:6978 has 617.50 million shares outstanding. The number of shares has increased by 18.23% in one year.
| Current Share Class | 617.50M |
| Shares Outstanding | 617.50M |
| Shares Change (YoY) | +18.23% |
| Shares Change (QoQ) | +13.38% |
| Owned by Insiders (%) | 34.62% |
| Owned by Institutions (%) | n/a |
| Float | 216.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -2.40 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.22
| Current Ratio | 0.22 |
| Quick Ratio | 0.14 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.49 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -20.57% |
| Return on Invested Capital (ROIC) | -66.75% |
| Return on Capital Employed (ROCE) | -507.34% |
| Weighted Average Cost of Capital (WACC) | 9.59% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.08M |
| Employee Count | 183 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -4,618 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.35% in the last 52 weeks. The beta is 0.12, so HKG:6978's price volatility has been lower than the market average.
| Beta (5Y) | 0.12 |
| 52-Week Price Change | -92.35% |
| 50-Day Moving Average | 0.47 |
| 200-Day Moving Average | 1.92 |
| Relative Strength Index (RSI) | 40.27 |
| Average Volume (20 Days) | 152,414 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -184.02M |
| Pretax Income | -198.28M |
| Net Income | -198.05M |
| EBITDA | -124.82M |
| EBIT | -184.02M |
| Earnings Per Share (EPS) | -0.33 |
Balance Sheet
The company has 71.29 million in cash and 116.29 million in debt, with a net cash position of -45.00 million or -0.07 per share.
| Cash & Cash Equivalents | 71.29M |
| Total Debt | 116.29M |
| Net Cash | -45.00M |
| Net Cash Per Share | -0.07 |
| Equity (Book Value) | -100.53M |
| Book Value Per Share | -0.15 |
| Working Capital | -402.09M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 59.80M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HKG:6978 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -18.23% |
| Shareholder Yield | -18.23% |
| Earnings Yield | -82.24% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |